Prelude Therapeutics Incorporated

NasdaqGS:PRLD Stock Report

Market Cap: US$52.8m

Prelude Therapeutics Incorporated Company Information

Prelude Therapeutics Incorporated's employee growth, exchange listings and data sources


Key Information

  • Name: Prelude Therapeutics Incorporated
  • Ticker: PRLD
  • Exchange: NasdaqGS
  • Founded: 2016
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$52.839m
  • Shares Outstanding: 55.04m
  • Website: https://preludetx.com

Number of Employees


Location

  • Prelude Therapeutics Incorporated
  • 175 Innovation Boulevard
  • Wilmington
  • Delaware
  • 19805
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PRLDNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDSep 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 21:47
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.